Ren Wujing, Xi Yue, Ma Yixuan, Duan Xinyan, Wang Tianmu, Yu Mengyuan, Qin Shuguang, Gong Da-Wei, Tian Zhenjun
Institute of Sports and Exercise Biology, Shaanxi Normal University, Xi'an, Shaanxi, People's Republic of China.
Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
FASEB J. 2025 Jun 30;39(12):e70734. doi: 10.1096/fj.202402897RR.
ELABELA (ELA) has been identified as a potential cardiovascular protective factor. However, the source of endogenous ELA and its molecular mechanism in myocardial fibrosis inhibition remain incompletely understood. Herein, we found that aerobic exercise significantly improved renal apoptosis caused by MI, inhibited inflammation, attenuated structural damage, enhanced renal function, and increased expression and secretion levels of renal ELA. Aerobic exercise stimulated the circulation of renal-derived ELA to reach the MI heart and played a protective role. Under aerobic exercise intervention, renal-specific Elabela overexpression improved myocardial pathological remodeling, decreased cardiomyocyte apoptosis, and enhanced cardiac function. Renal-specific Elabela knockdown significantly increased cardiac apoptosis, inflammation, and fibrosis levels in MI mice, leading to severe impairment of cardiac function. Following AMPK agonist intervention, ELA expression in HKC cells and culture medium increased in a concentration-dependent manner. ELA-14 significantly activated the APJ-AMPK-Sirt1 signaling pathway and inhibited Tgf-β1 transcription by regulating Sirt1 translocation, and AMPK inhibitor weakened ELA-14 function. In cultured cardiac fibroblasts (CFs), the intervention of ELA-14 significantly inhibited the activity of the TGFβ1-Smad2/3 signaling pathway, downregulated the expression of fibrosis-related proteins, increased apoptosis, and lowered the cell migration rate. After TGFβR1 inhibitor intervention, ELA-14 showed a loss of regulation of CFs. Aerobic exercise stimulates the expression of renal-derived ELA, which reaches the MI heart through blood circulation. Renal-derived ELA partly exerts its antifibrotic effects by activating the APJ-AMPK-Sirt1 pathway and inhibiting the TGFβ1-Smad2/3 signaling pathway, contributing to its cardiac protective effects.
埃拉贝拉(ELA)已被确认为一种潜在的心血管保护因子。然而,内源性ELA的来源及其抑制心肌纤维化的分子机制仍未完全明确。在此,我们发现有氧运动显著改善了心肌梗死所致的肾脏细胞凋亡,抑制了炎症反应,减轻了结构损伤,增强了肾功能,并提高了肾脏ELA的表达和分泌水平。有氧运动促使肾脏来源的ELA循环至心肌梗死心脏并发挥保护作用。在有氧运动干预下,肾脏特异性埃拉贝拉过表达改善了心肌病理重塑,减少了心肌细胞凋亡,并增强了心脏功能。肾脏特异性埃拉贝拉基因敲低显著增加了心肌梗死小鼠的心脏细胞凋亡、炎症和纤维化水平,导致心脏功能严重受损。在AMPK激动剂干预后,人肾小管上皮细胞(HKC)中及培养基中的ELA表达呈浓度依赖性增加。ELA-14通过调节沉默调节蛋白1(Sirt1)易位显著激活了无活性蛋白受体(APJ)-AMPK-Sirt1信号通路并抑制了转化生长因子-β1(Tgf-β1)转录,而AMPK抑制剂削弱了ELA-14的功能。在培养的心脏成纤维细胞(CFs)中,ELA-14干预显著抑制了TGFβ1-Smad2/3信号通路的活性,下调了纤维化相关蛋白的表达,增加了细胞凋亡,并降低了细胞迁移率。在转化生长因子β受体1(TGFβR1)抑制剂干预后,ELA-14对CFs的调节作用丧失。有氧运动刺激肾脏来源的ELA表达,其通过血液循环到达心肌梗死心脏。肾脏来源的ELA部分通过激活APJ-AMPK-Sirt1通路和抑制TGFβ1-Smad2/3信号通路发挥其抗纤维化作用,从而产生心脏保护作用。